MDM4 and melanoma: Intriguingly, antisense oligonucleotide–mediated skipping of exon 6 decreased MdmX abundance, inhibited melanoma growth, and enhanced sensitivity to BRAF inhibitors in human melanoma cell lines and melanoma patient–derived xenografts [10].